Efficacy of anti-PD1/PDL1 antibody monotherapy in patients with advanced non-small cell lung cancer with increased hepcidin expression

被引：0
|
作者：
Yamamoto, M. [1 ]
Hirama, N. [1 ]
Teranishi, S. [1 ]
Tashiro, K. [1 ]
Kubo, S. [2 ]
Kudo, M. [1 ]
Kaneko, T. [2 ]
机构：
[1] Yokohama City Univ Med Ctr, Resp Dis Ctr, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Dept Respirol, Yokohama, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1473P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of anti-PD1 therapy for metastatic melanoma and non-small cell lung cancer in patients with concurrent viral hepatitis
    Kothapalli, A.
    Khattak, M.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 79 - 79
  • [32] CD155 expression impairs anti-PD1 therapy response in non-small cell lung cancer
    Jiang, Chang
    Qu, Xiaodie
    Ma, Li
    Yi, Ling
    Cheng, Xu
    Gao, Xiang
    Wang, Jinghui
    Che, Nanying
    Zhang, Hongtao
    Zhang, Shucai
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 208 (02): : 220 - 232
  • [33] Efficacy and safety of PD1/PDL1 blockades versus docetaxel in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis
    Liu, Jixiang
    Zhong, Yulan
    Peng, Shanshan
    Zhou, Xiangxiang
    Gan, Xin
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 8623 - 8632
  • [34] Exploratory analysis of factors associated with hyperprogression in advanced non-small cell lung cancer (NSCLC) treated with PD1/PDL1 inhibitors.
    Decatris, Marios P.
    Thomas, Joy A.
    Hayes, Mark
    Ryan, Philip
    Phillips, Aled
    ElBatrawy, Sherouk
    Bowden, Caitlin
    Du Rand, Ingrid
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer
    Shibaki, Ryota
    Murakami, Shuji
    Shinno, Yuki
    Matsumoto, Yuji
    Goto, Yasushi
    Kanda, Shintaro
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Motoi, Noriko
    Yamamoto, Noboru
    Ohe, Yuichiro
    [J]. THORACIC CANCER, 2019, 10 (04) : 815 - 822
  • [36] Cardiac Troponin-I Elevation in Patients with Non-Small Cell Lung Cancer during PD1/PDL1 Inhibition with Nivolumab
    Rijavec, Erika
    Genova, Carlo
    Sarocchi, Matteo
    Musu, Simone
    Arboscello, Eleonora
    Bellodi, Andrea
    Barletta, Giulia
    Biello, Federica
    Rossi, Giovanni
    Maggioni, Claudia
    Dal Bello, Maria Giovanna
    Brunelli, Claudio
    Mussap, Michele
    Spallarossa, Paolo
    Grossi, Francesco
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1324 - S1324
  • [37] Immune-Omics Networks of CD27, PD1, and PDL1 in Non-Small Cell Lung Cancer
    Ye, Qing
    Singh, Salvi
    Qian, Peter R.
    Guo, Nancy Lan
    [J]. CANCERS, 2021, 13 (17)
  • [38] Complete response with anti-PD-L1 antibody following progression on anti-PD-1 antibody in advanced non-small cell lung cancer
    Singh, Navdeep
    Seetharamu, Nagashree
    [J]. BMJ CASE REPORTS, 2020, 13 (08)
  • [39] Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non-Small Cell Lung Cancer With a PD-L1 Expression ≥50%
    Metro, Giulio
    Banna, Giuseppe Luigi
    Signorelli, Diego
    Gili, Alessio
    Galetta, Domenico
    Galli, Giulia
    Economopoulou, Panagiota
    Roila, Fausto
    Friedlaender, Alex
    Camerini, Andrea
    Christopoulou, Athina
    Cantale, Ornella
    De Toma, Alessandro
    Pizzutilo, Pamela
    Jimenez, Beatriz
    Collazo-Lorduy, Ana
    Calles, Antonio
    Baxevanos, Panagiotis
    Linardou, Helena
    Kosmidis, Paris
    Giannarelli, Diana
    Mountzios, Giannis
    Addeo, Alfredo
    [J]. JOURNAL OF IMMUNOTHERAPY, 2020, 43 (09) : 299 - 306
  • [40] Soluble immune biomarkers to anti-PD1 treatment in non-small cell lung cancer (NSCLC)
    Garde-Noguera, J.
    Jantus-Lewintre, E.
    Honrubia Peris, B.
    Gallach Garcia, S.
    Zhang, F.
    Garcia Sanchez, J.
    Calabuig Farinas, S.
    Blasco Cordellat, A.
    Piera Molons, N.
    Vidal-Martinez, J.
    Murado-Pardo, J.
    Condori Farfan, L. D.
    Gisbert-Criado, R.
    Escorihuela, E.
    Camps, C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345